Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience  Tetsuma Kawaji, Satoshi.

Slides:



Advertisements
Similar presentations
Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.
Advertisements

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
From: Incidence, Predictive Factors, and Prognostic Value of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation J Am Coll.
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.
Volume 70, Issue 1, Pages (July 2017)
Figure 1 Flow chart diagram of high-risk group AF patients
Volume 55, Issue 3, Pages (May 2010)
Volume 28, Issue 6, Pages (December 2012)
Frontiers of anticoagulation therapy for atrial fibrillation
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.
Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery  Emmanuel Akintoye, MD, MPH, Frank Sellke, MD,
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal  Gregory.
Role of the CHADS2 Score in Acute Coronary Syndromes
Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B
CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy  Svetlana Kotova, MD, Mansen Wang, PhD, Katie.
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control 
Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation  Lena Rivard, MD, MSc, Paul Khairy, MD,
Nat. Rev. Cardiol. doi: /nrcardio
Epicardial and endocardial electrophysiological guided thoracoscopic surgery for atrial fibrillation: A multidisciplinary approach of atrial fibrillation.
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Comparison of chronic type A aortic dissection with acute type A dissection of short-term and long-term survival rate  Qinghua Yuan, Hui Yu, Ujit Karmacharya,
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,
International Journal of Cardiology
Intermediate to Long-Term Results of Radiofrequency Modified Maze Procedure as an Adjunct to Open-Heart Surgery  Willem P. Beukema, MD, Hauw T. Sie, MD,
Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD 
Cardiovascular disease in patients with osteogenesis imperfecta — a nationwide, register-based cohort study  Lars Folkestad, Jannie Dahl Hald, Jeppe Gram,
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease  Renato D. Lopes, MD, MHS, PhD, Meena Rao, MD,
CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation
Development of a risk of stroke score in the Lebanese population
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.
Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population  Paul D. Ziegler, John D. Rogers,
Truman J. Milling, MD, Alex C. Spyropoulos, MD 
James L. Cox, MD, Niv Ad, MD, Terry Palazzo, RN, MS 
Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Volume 15, Issue 12, Pages (December 2018)
Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review  B.A. de Waal, M.P. Buise, A.A.J. van.
Optimizing Atrial Fibrillation Management
Epicardial and endocardial electrophysiological guided thoracoscopic surgery for atrial fibrillation: A multidisciplinary approach of atrial fibrillation.
Competing risks need to be considered in survival analysis models for cardiovascular outcomes  Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.
International Journal of Cardiology
Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different.
Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012  A.C.E.
Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection  Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.
Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery  Su-Kiat Chua, MD,
Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations  Willem J. Verberk, Stefano.
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
International Journal of Cardiology
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression  Corline Brouwers, Stefan.
Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study  Walid Saliba, MD, MPH, Naomi.
International Journal of Cardiology
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Maura Marcucci, MD, Gregory Y.H. Lip,
International Journal of Cardiology
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
A Brugada-like electrocardiogram pattern induced after radiofrequency catheter ablation of atrial fibrillation  Chunying Jiang, Rui Wang, Wen Lu, Bing.
International Journal of Cardiology
Erratum Canadian Journal of Cardiology
SAFETY AND EFFICACY OF DABIGATRAN COMPARED TO BRIDGED WARFARIN FOR PERIPROCEDURAL ANTICOAGULATION IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR.
Should patient age be a consideration in carotid endarterectomy?
Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation  Finlay A. McAlister,
Volume 5, Issue 11, Pages (November 2008)
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Figure 8. Stroke prevention strategy in patients with AF
Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc.
The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.
Presentation transcript:

Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience  Tetsuma Kawaji, Satoshi Shizuta, Takeshi Morimoto, Takanori Aizawa, Shintaro Yamagami, Takashi Yoshizawa, Chihiro Ota, Naoaki Onishi, Yasuhiro Sasaki, Mitsuhiko Yahata, Kentaro Nakai, Mamoru Hayano, Tetsushi Nakao, Koji Hanazawa, Koji Goto, Takahiro Doi, Koh Ono, Takeshi Kimura  International Journal of Cardiology  Volume 249, Pages 204-213 (December 2017) DOI: 10.1016/j.ijcard.2017.09.023 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Event-free survival from recurrent atrial tachyarrhythmias. Event-free survival from recurrent atrial tachyarrhythmias with a blanking period of 90days; (A) after the initial procedure, (B) after the last procedure, (C) after the initial procedure according to AF type, and (D) after the last procedure according to AF type. AF=atrial fibrillation, LlAF=long-lasting AF, PAF=paroxysmal AF, and PeAF=persistent AF. International Journal of Cardiology 2017 249, 204-213DOI: (10.1016/j.ijcard.2017.09.023) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Survival-free curves from clinical outcomes during follow-up. Survival-free curves from all-cause death and cardiovascular death in the entire population (A) and those from all cause death according to AF type (B). Survival-free curves from heart failure hospitalization in the entire population (C) and in patients stratified according to AF type (D). Survival-free curves from stroke in the entire population (E) and in patients stratified according to AF type (F). Survival-free curves from major bleeding in the entire population (G) and in patients stratified according to AF type (H). AF=atrial fibrillation, LlAF=long-lasting AF, PAF=paroxysmal AF, and PeAF=persistent AF. International Journal of Cardiology 2017 249, 204-213DOI: (10.1016/j.ijcard.2017.09.023) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Survival-free curves from clinical outcomes during follow-up. Survival-free curves from all-cause death and cardiovascular death in the entire population (A) and those from all cause death according to AF type (B). Survival-free curves from heart failure hospitalization in the entire population (C) and in patients stratified according to AF type (D). Survival-free curves from stroke in the entire population (E) and in patients stratified according to AF type (F). Survival-free curves from major bleeding in the entire population (G) and in patients stratified according to AF type (H). AF=atrial fibrillation, LlAF=long-lasting AF, PAF=paroxysmal AF, and PeAF=persistent AF. International Journal of Cardiology 2017 249, 204-213DOI: (10.1016/j.ijcard.2017.09.023) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Cumulative incidence of OAC discontinuation. Cumulative incidence of OAC discontinuation in the entire population (A), in patients stratified according to AF type (B), and in patients stratified according to CHA2DS2-VASC score (C). AF=atrial fibrillation, LlAF=long-lasting AF, PAF=paroxysmal AF, and PeAF=persistent AF. International Journal of Cardiology 2017 249, 204-213DOI: (10.1016/j.ijcard.2017.09.023) Copyright © 2017 The Authors Terms and Conditions

Fig. 4 Details of ischemic stroke and major bleeding. A) Pathogenesis of ischemic stroke and source of major bleeding, and B) antithrombotic therapy at the time of events. DAPT=dual antiplatelet therapy, SAPT=single antiplatelet therapy, OAC=oral anticoagulation. International Journal of Cardiology 2017 249, 204-213DOI: (10.1016/j.ijcard.2017.09.023) Copyright © 2017 The Authors Terms and Conditions